Ozempic risk: could weight loss injections be fatal?

💉
The pharmaceutical world is currently experiencing a seismic shift, largely driven by a drug originally developed to treat diabetes: Ozempic (semaglutide). Its unintended, yet highly attractive, side effect—dramatic weight loss—has fueled a revolution in cosmetic body transformation, particularly in Hollywood. However, this explosion in popularity, and the rush to prescribe it off-label for cosmetic purposes, is raising alarm bells among medical experts, regulators, and those personally impacted by its potential dangers.
A recent investigative report by 60 Minutes Australia delves into the dark side of this “miracle drug,” featuring a tragic casualty and scrutinizing the online companies capitalizing on the demand.
💔 The Ultimate Cost: The Story of Trish Webster
The most potent warning comes from the family of Trish Webster, a 56-year-old Australian woman whose desire to lose weight for her daughter’s wedding led her to take Ozempic alongside another weight loss drug, Saxenda.

• Fatal Side Effects: While taking the medication, Trish suffered from chronic and severe nausea and diarrhea. She died in January 2023. Her death certificate cited an acute gastrointestinal illness as the cause.
• Husband’s Plea: Her grieving husband, Roy Webster, is adamant that the drugs were the root cause of her death and is fighting for a coronial inquest. He wants to ensure others are warned of the potential for a fatal outcome.
  This case stands as a stark warning, forcing a crucial conversation about the difference between managing a serious disease and pursuing cosmetic weight loss.
  🔬 The Science of Weight Loss: How Semaglutide Works
  Ozempic’s active ingredient, semaglutide, is a GLP-1 receptor agonist. GLP-1 is a naturally occurring hormone that plays a key role in regulating blood sugar and appetite.
  Semaglutide works in two primary ways to facilitate weight loss:
• Slowing Digestion: It mimics the GLP-1 hormone, signaling the stomach to empty more slowly. This process keeps the user feeling fuller for a longer period.
• Suppressing Appetite: It acts on the brain to suppress hunger cravings, naturally leading to a reduced caloric intake.
  While this mechanism is highly effective for weight management and for treating diabetes, it is also the source of the drug’s most serious and potentially lethal side effects, particularly those related to the gastrointestinal tract.
  🚨 Regulatory Response and Medical Risks
  The death of Trish Webster, along with other cases and lawsuits, has spurred regulators and pharmaceutical companies into action, albeit belatedly.
  The Risk of Acute Gastrointestinal Illness
• Ileus Warning: In the U.S., the Food and Drug Administration (FDA) has had to update product information for Ozempic and similar drugs to include warnings for ileus—a severe condition where the digestive tract is blocked or paralyzed.
• Post-Marketing Awareness: The drug’s manufacturer, Novo Nordisk, conceded that ileus was only reported in the “post-marketing setting,” meaning the problem was recognized after the drug was already widely distributed to the public.
• Risk Profile: Endocrinologist Dr. Katherine Williams stresses that while the active ingredient can cause digestive complications, the absolute risk of a severe event like ileus is considered very low. However, she cautions that inadequate patient counseling and monitoring by prescribing physicians dramatically increases the risk.
  💰 The Telehealth Gold Rush: Money Over Morals?
  The investigation heavily scrutinizes the booming online telehealth industry that has enabled easy, rapid access to Ozempic, often skirting established medical guidelines.
  The Rise of Juniper
  Online providers like Juniper have become massive commercial successes. The CEO of Juniper reported the company’s annual revenue at over $150 million. Their model simplifies the prescription process through:
• Online Screening: Patients answer a 50-question online quiz about their health and weight loss goals.
• Remote Consultation: This is followed by a tele-health consultation with a doctor who prescribes the drug.
• Direct-to-Door Delivery: The medication is then delivered directly to the patient’s home.
  Ethical and Safety Lapses
  Critics argue that this high-volume, remote model prioritizes profit over patient safety, creating dangerous loopholes:
• Off-Label Prescribing: The TGA (Therapeutic Goods Administration) has warned against prescribing Ozempic for weight loss, as it was intended for diabetes, but doctors are technically allowed to prescribe it “off-label”.
• Falsified Information: Psychiatrist Professor Elizabeth Scott, who treats patients with eating disorders, warned that the current process makes it far too easy for people to falsify their information to gain access to the drug. For individuals with conditions like anorexia or bulimia, easy access to a powerful appetite suppressant is described as a “bullet train to the grave”.
• Profit Defense: When challenged on the ethics of the online model, the CEO of Juniper defended their actions by asserting it is ethical, claiming, “ultimately helping patients with their weight loss journeys and helping them avoid chronic disease is an important job”.
  The commercial frenzy has not only put certain patients at risk but has also contributed to a global shortage of Ozempic, making it difficult for the diabetic patients for whom the drug was originally intended to access their necessary medication.
  ⚖️ A Call for Regulation and Vigilance
  The story of Ozempic serves as a cautionary tale about the intersection of social trends, cosmetic demands, and complex pharmaceuticals.
  While these medications offer genuine hope and effective treatment for those battling the disease of obesity, their rapid, unsupervised, and often cosmetic use is exposing a crucial gap in healthcare regulation and ethical practice. The plea from Roy Webster—who is determined to ensure his wife’s death was not in vain—is a call to action for stricter oversight, more thorough patient counseling, and a commitment to ensuring that the accessibility of powerful drugs does not come at the expense of human life.

About The Author

LAJONG11

See author's posts